• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SPY
Click for more information
3.17% 65.0¢

Smartpay Holdings Limited - Charts / Financials

watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Day
Open 63.0¢   Day High 65.5¢   Day Low 63.0¢
Daily Volume 4558
Bids   Sellers
Number Price Volume   Number Price Volume
0 67.5¢ 6   0 72.5¢ 7547

Data source: Refinitiv

(20min delay)
Last
65.0¢ 		Change
0.020(3.17%) 		Mkt cap ! n/a
Open High Low Value Volume
63.0¢ 65.5¢ 63.0¢ $2.915K 4.558K

Buyers (Bids)

No. Vol. Price($)
0 6 67.5¢
 

Sellers (Offers)

Price($) Vol. No.
72.5¢ 7547 0
Last trade - 10.53am 22/11/2024 (20 minute delay) ?

Top Stories

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.